39 research outputs found
Primer Extension Enrichment Reaction (PEER): a new subtraction method for identification of genetic differences between biological specimens
We developed a conceptually new subtraction strategy for the detection and isolation of target DNA and/or RNA from complex nucleic acid mixtures, called Primer Extension Enrichment Reaction (PEER). PEER uses adapters and class IIS restriction enzymes to generate tagged oligonucleotides from dsDNA fragments derived from specimens containing an unknown target (‘tester’). Subtraction is achieved by selectively disabling these oligonucleotides by extension reaction using ddNTPs and a double stranded DNA template generated from a pool of normal specimens (‘driver’). Primers that do not acquire ddNTP are used to capture and amplify the unique target DNA from the original tester dsDNA. We successfully applied PEER to specimens containing known infectious agents (Hepatitis B Virus and Walrus Calicivirus) and demonstrated that it has higher efficiency than the best comparable technique. The strategy used for PEER is versatile and can be adapted for the identification of known and unknown pathogens and mutations, differential expression studies and other applications that allow the use of subtractive strategies
Huntingtin forms toxic NH2-terminal fragment complexes that are promoted by the age-dependent decrease in proteasome activity
Although NH2-terminal mutant huntingtin (htt) fragments cause neurological disorders in Huntington's disease (HD), it is unclear how toxic htt fragments are generated and contribute to the disease process. Here, we report that complex NH2-terminal mutant htt fragments smaller than the first 508 amino acids were generated in htt-transfected cells and HD knockin mouse brains. These fragments constituted neuronal nuclear inclusions and appeared before neurological symptoms. The accumulation and aggregation of these htt fragments were associated with an age-dependent decrease in proteasome activity and were promoted by inhibition of proteasome activity. These results suggest that decreased proteasome activity contributes to late onset htt toxicity and that restoring the ability to remove NH2-terminal fragments will provide a more effective therapy for HD than inhibiting their production
Recommended from our members
Waterways to Greenways: A Case Study in Shangjie, Zhengzhou, Henan, China
This case study introduces how we used a water sensitive approach to plan a storm water and sponge city project, which expanded into a holistic green infrastructure project. The project is in the Shangjie district in city of Zhengzhou, Henan China. The whole site is 61.16 km² including several waterways. The city is expanding into areas that were previously agricultural. Developers and city both desire to improve the ecological value of the city to boost the economic growth of the Shangjie district.
The main goal for the client is to transform the existing industrial city into a more resilient and livable ecological region. Our approach is to holistically solve the region\u27s increasing demand for flood control and storm water management, and to improve ecological and recreational values along these riparian corridors. We propose additional waterways and water bodies to act as green infrastructure, then link the greenways to existing or proposed parks to form a comprehensive greenway network.
Our multidisciplinary team conducted detailed investigations and collaborated extensively. The team consists of hydraulic engineers, civil engineers, environmental planners, landscape planners, urban planners, economic planners, and others. We used a variety of technologies, including GIS, Infoworks, remote sensing technology, MIKE model, and lab tests
A cross-cultural study of domestic luminous environment in the United Kingdom and Japan
Abstract not available
Tirofiban for Stroke without Large or Medium-Sized Vessel Occlusion
The effects of the glycoprotein IIb/IIIa receptor inhibitor tirofiban in patients with acute ischemic stroke but who have no evidence of complete occlusion of large or medium-sized vessels have not been extensively studied. In a multicenter trial in China, we enrolled patients with ischemic stroke without occlusion of large or medium-sized vessels and with a National Institutes of Health Stroke Scale score of 5 or more and at least one moderately to severely weak limb. Eligible patients had any of four clinical presentations: ineligible for thrombolysis or thrombectomy and within 24 hours after the patient was last known to be well; progression of stroke symptoms 24 to 96 hours after onset; early neurologic deterioration after thrombolysis; or thrombolysis with no improvement at 4 to 24 hours. Patients were assigned to receive intravenous tirofiban (plus oral placebo) or oral aspirin (100 mg per day, plus intravenous placebo) for 2 days; all patients then received oral aspirin until day 90. The primary efficacy end point was an excellent outcome, defined as a score of 0 or 1 on the modified Rankin scale (range, 0 [no symptoms] to 6 [death]) at 90 days. Secondary end points included functional independence at 90 days and a quality-of-life score. The primary safety end points were death and symptomatic intracranial hemorrhage. A total of 606 patients were assigned to the tirofiban group and 571 to the aspirin group. Most patients had small infarctions that were presumed to be atherosclerotic. The percentage of patients with a score of 0 or 1 on the modified Rankin scale at 90 days was 29.1% with tirofiban and 22.2% with aspirin (adjusted risk ratio, 1.26; 95% confidence interval, 1.04 to 1.53, P = 0.02). Results for secondary end points were generally not consistent with the results of the primary analysis. Mortality was similar in the two groups. The incidence of symptomatic intracranial hemorrhage was 1.0% in the tirofiban group and 0% in the aspirin group. In this trial involving heterogeneous groups of patients with stroke of recent onset or progression of stroke symptoms and nonoccluded large and medium-sized cerebral vessels, intravenous tirofiban was associated with a greater likelihood of an excellent outcome than low-dose aspirin. Incidences of intracranial hemorrhages were low but slightly higher with tirofiban
Periodic solutions for a class of higher-order Cohen–Grossberg type neural networks with delays
AbstractSufficient conditions are obtained for the existence and global attractivity of periodic solutions of a class of higher-order Cohen–Grossberg type neural networks with delays. The proof is based on Gaines and Mawhin’s continuation theorem of coincidence degree theory, the Lyapunov functional and a nonsingular M-matrix. One example is exploited to illustrate the effectiveness of the proposed criteria